Posts Tagged ‘ Drug Recalls’

Drug Recalls: Is Avandia Next?

Wednesday, July 28th, 2010

On July 16, 2010, the Food and Drug Administration (FDA) decided to keep the diabetes drug Avandia (rosiglitazone) on the market despite a cardiovascular threat to some patients. Conflicting studies have shown that the drug rosiglitazone promotes increased cardiovascular risk to patients with diabetes.

The FDA, as well as the Endocrine Society, the American Association of Clinical Endocrinologists and the American Diabetes Association, have issued warnings that stopping the drug abruptly may cause a patient more serious short-term health problems and complications.

It is the recommendation of the Southern California drug recall attorneys at the Law Offices of Samer Habbas to speak to your doctor before discontinuing any medication. Oftentimes, people hear reports on the news about defective drugs and suddenly stop taking their medication. The withdrawal effects of abruptly stopping any diabetes medication can result in a rise in blood glucose that can cause complications in the future.

There are alternative medications other than Avandia for diabetes that you can consider if you are at a high risk for cardiovascular episodes. Call your healthcare care provider as soon as possible to determine whether one of these other medications would be right for you.

If you have experienced health problems due to Avandia, you should report them to your doctor right away. You should write down what happened each time and keep the medication bottle. Keeping accurate records of any Avandia drug complications would be crucial if stores pull the product from their shelves.

At The Law Offices of Samer Habbas, we have a team of drug recall attorneys who are here to answer any questions you have. Feel free to call us with questions about the Avandia drug recall at 888.848.5084 or visit our website for up-to-date news on how our civil litigation department is helping clients who have taken defective medication.

Two People Extracted from Wreckage of California Boating Accident

Monday, April 26th, 2010

A watercraft accident at Lake Havasu resulted in all aboard being injured and the extraction of two Chino men from the wreckage. Accident investigators say the accident occurred near California Cove in Needles late in the evening on April 16. San Bernardino County Sheriff’s personnel responding to the accident found the wreckage of the large ski boat around 10:30 p.m. that evening in the desert nearly 50 feet from the shoreline.

The Chino men were found trapped inside the wreckage and had to be pulled from under the boat’s steering wheel and passenger side glove compartment by firefighters. One of the men and two other passengers were airlifted to area trauma centers. Deputies believe that one of the trapped men was driving the 21-foot Shockwave ski boat at about 50 mph around 10 p.m. that evening toward a launch ramp when it struck the shoreline. The investigation is ongoing, but deputies believe that alcohol was a contributing factor in the accident.

California watercraft and boating accident lawyer Samer Habbas would like to remind boaters that boat operators with blood-alcohol concentrations above the legal limit are more than ten times more likely to be fatally injured in an accident than sober boaters. He and other Southern California watercraft and boating accident attorneys would also like to remind boating enthusiasts that more than one-third of all boating and watercraft accidents involve alcohol. In alcohol-related boating accidents, roughly two-thirds of fatalities are passengers.

People who operate watercrafts from jet skis to aircraft carriers have an obligation to operate their vessels in a safe and responsible manner. If negligence is found to be a contributing factor in an accident, operators can be held liable for damages. If you or someone you care for has been injured or killed in an accident caused by a negligent operator, call 888.848.5084 to schedule a free consultation with Long Beach watercraft and boating accident lawyer Samer Habbas.

Resource link:  Two People Extracted from Wreckage of California Boating Accident

Drug Company Issues Voluntary Recall of Drug

Tuesday, December 22nd, 2009

Prescription drug manufacturer American Regent has issued a voluntary recall of every lot of their ketorolac tromethamine injection, 30 mg/ml product. The US Food and Drug Administration (FDA) announced recently that particulate matter and crystallization might be present in the drug that could result in obstruction of blood vessels. If a person injects the drug and particulate matter and crystallization is present, it could induce pulmonary emboli or thrombosis or activate platelets and/or neutrophils to induce anaphylactic reactions.

“Other adverse effects associated with the injection of particulate matter include foreign body granulomas, and local irritation at the injection site,” according to an alert sent yesterday from Med Watch, the FDA’s safety information and adverse event reporting program. (more…)

Children’s Tylenol Recalled

Thursday, October 22nd, 2009

This Newsday article claims that the McNeil unit of Johnson & Johnson has voluntarily recalled 57 lots of infants and children’s liquid Tylenol products due to the possibility of bacterial contamination. The Tylenol products manufactured between April and June 2009 included almost two dozen varieties subject to the recall. Johnson & Johnson has said publicly that an inactive ingredient in the various types of product did not meet the company’s internal testing requirements and B. cepacia bacteria was found in a part of the unused material.

The company composed a letter that stated they found no bacteria in the finished product sold to the public, and the possibility of someone becoming seriously ill from contamination of their product was very remote. However, after a consultation with the Food and Drug Administration, the company decided that they would recall the products.

(more…)

FDA Recalls Hydroxycut

Friday, May 8th, 2009

The United States Food and Drug Administration (FDA) has officially warned consumers to discontinue using the popular weight loss product, Hydroxycut. In a press release issued May 1, 2009, the FDA made the warning about the product after receiving numerous reports of serious liver damage among those using the dietary supplement products. As of the time of the recall announcement, Hydroxycut has been involved in at least one death due to liver failure. Other serious health effects that have been reported include cardiovascular disorders, seizures, kidney failure and muscle damage.

Iovate Health Science, Inc. manufactures Hydroxycut and Iovate Health Sciences USA, Inc., handles the distribution. In addition to being marketed as a weight loss supplement, the product has been touted as a low carb diet supplement and an energy enhancer. The manufacturer has agreed to a voluntary recall of over a dozen Hydroxycut products:

(more…)